Market Overview

Provant Health Enters into Asset Purchase Agreement with Summit Health, Inc., Subsidiary of Quest Diagnostics


Hooper Holmes, Inc. d/b/a Provant Health (OTCQX:HPHW) ("Provant Health"
or the "Company"), the largest publicly traded, pure-play health and
well-being provider in the U.S., today announced that it has entered
into an asset purchase agreement with Summit Health, Inc., a subsidiary
of Quest Diagnostics ("Quest"), the world's leading provider of
diagnostic testing, information, and services.

Under the asset purchase agreement, Quest will acquire substantially all
of Provant Health's assets and will continue the Company's service
offerings as it has in the past. Throughout the transaction process,
Provant Health will continue to serve its customers, remaining focused
on meeting customer and partner obligations in the busy fourth quarter
season. Upon completion of the transaction, Quest will lend its history,
expertise, and resources in the health care space to enhance the
experiences of Provant Health's customers and partners.

Mark Clermont, president of Provant Health, commented, "We believe that
the purchase of Provant Health by Quest will extend greater value to our
customers and partners than ever before. Quest recognized that Provant
Health's comprehensive services add valuable programs, people and
technology to its offerings. Quest's reach in its space is unrivaled,
and its knowledge, resources, and capabilities will only enhance the
experiences of those we serve."

To support Provant Health in meeting its working capital requirements
during the sale process, the Company has signed definitive agreements
with its two primary lenders, SWK and CNH, to provide up to $13.6 MM,
that will allow the Company to continue to operate the business through
closing of the sale which is anticipated to be on or before the tenth of
October. The Quest asset purchase agreement is valued at $27 million
dollars and takes the form of a "stalking horse" bid, with the sale to
be completed after an auction process carried out under the terms of
section 363 of the bankruptcy code. The Quest asset purchase agreement
also contains a transition services agreement "TSA" through December 31,
2018, to ensure a smooth client transition and seamless continued

"After the merger of Hooper Holmes and Provant in 2017, the combined
company was saddled with a significant working capital shortfall, an
over-leveraged balance sheet and experienced significant losses in 2017.
Through this acquisition by Quest, the Company is now positioned for
success," noted Jim Fleet, chief restructuring officer/senior executive
in charge of Provant Health.

In conjunction with the sale process, the Company petitioned for Chapter
11 bankruptcy on Monday, August 27, 2018, to facilitate a rapid 363 sale
process with an anticipated transaction close date on or before of the
tenth of October 2018.

Provant Health underscores its continued commitment to serving its
customers and employees as it undergoes this strategic transition.

About Provant Health

Hooper Holmes, Inc. d/b/a Provant Health, is a national leader in
comprehensive workplace well-being and clinical research support
services, with a growing global presence. The company partners with
employers and brokers to improve members' whole-person health and
productivity, and to support health care cost management. Provant Health
touches millions of lives by delivering customized well-being strategies
and services on-site, telephonically and digitally, utilizing advanced
data management technology. The company's innovative platform includes
flexible program designs, incentive management, biometric screenings,
health coaching and condition management, data analytics, health care
advocacy, and a portal that serves as the hub for program activities,
benefits, communications, and specialty experts. In addition, Provant
Health's national network of health professionals provides laboratory
testing, risk assessment and sample collection services to wellness and
disease management companies, employers and brokers, government
organizations and academic institutions nationwide. Provant Health will
continue in the marketplace for over-the-counter stocks as HPHW

Forward-looking Statements

This release contains forward-looking statements within the meaning of
the federal securities laws. Forward-looking statements may generally be
identified by the use of words such as "anticipate," "believe,"
"expect," "intends," "plan," and "will" or, in each case, their
negative, and other variations or comparable terminology. These
forward-looking statements include all statements other than historical
facts. Any forward-looking statement made in this release is not a
guarantee of future performance, and actual results may differ
materially from those expressed in or suggested by the forward-looking
statements, as a result of various factors, including, without
limitation the factors discussed in the "Risk Factors" section of the
company's Annual Report on Form 10-K for the year ended December 31,
2017, as the same may be updated from time-to-time in subsequent filings
with the Securities and Exchange Commission. Any forward-looking
statement made in this release speaks only as of the date hereof, and
the Company has no obligation, and does not intend, to update any
forward-looking statements after the date hereof, except as required by
federal securities laws.

View Comments and Join the Discussion!